DAL vs NAGE · P/E 12, rev $61.64B vs P/E 59, rev $99.6M
Delta Air Lines Inc (DAL) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported NAGE revenue for 2024-12-31 was $99.6M. Net income was $8.6M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the DAL and NAGE stock pages for the full models.
Not investment advice.